Applications and Use Cases

KPMG, Walmart, IBM and Merck Make DLT Plea to FDA

May 04, 2020

It’s nice to know where what we put in our bodies comes from – especially medicine. During February’s Cannabis on the Blockchain and #TechSuperShow, speakers enlightened attendees with how blockchain can support an exploding industry in gaining credibility across the supply chain via visibility. But, it’s not just cannabis applying blockchain to the supply chain.

In June 2019, IBM, Walmart, Merck and KPMG teamed up on a drug-tracing blockchain pilot program for the FDA. Today, the joint venture unveiled its results to the FDA, with the confidence this DLT (distributed ledger technology) is the solution to the U.S. Drug Supply Chain Security Act (DSCSA).

“With the use of a blockchain-enabled solution, this technology might be able to address the foundational requirement of track and trace for DSCSA in addition to establishing trust between trading partners,” the report said.

Of the 20 pilots currently participating in the FDA’s DSCSA program, DLT and blockchain are popular means to bring together a fractured supply chain, deliver enhanced transparency and improved product safety.

"The pharma supply chain is really incredibly complex, given the number of entities and logistics providers and distributors," said Tegan Keele, KPMG's blockchain lead. All these players use different systems – oftentimes, these systems fail to meet DSCSA's interoperability requirements. The consortium's hypothesis was that blockchain could be their information bridge, she continued.

Blockchain and DLT are finding a sweet spot in the supply chain, from the FDA to finance and more.

Edited by Maurice Nagle



Social media is impacting the value of your cryptocurrency. This cross-platform audit will show how to improve consumer and influencer sentiment.